You are here

Medical Testing

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies

Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UK reports nursing home COVID outbreak; U.S. shows slow but steady increase

In a technical briefing on SARS-CoV-2 variants today, the UK Health Security Agency (HSA) revealed that, of 34 confirmed involving the highly mutated BA.2.86 variant, 28 were from a single outbreak at a nursing home, an early sign that it can spread in close-contact settings.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 0.614 seconds.